Prosecution Insights
Prosecution Insights
Technology area: Computing & Software
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guagndong Feipeng Biological Co. Ltd. is currently active in the Computing & Software technology area. The company's patent portfolio includes 1 pending office action, which is the only active matter currently being prosecuted. STCLAIR, ANDREW D is the busiest examiner for the company and is responsible for this single pending action. The activity in this sector suggests a focus on digital or algorithmic innovations.
The prosecution profile is highly centralized, involving 1 distinct examiner and a distinct art unit. Because STCLAIR, ANDREW D is handling the busiest examiner pending action, the company's immediate success in the Computing & Software sector depends on the review of this individual examiner. This concentration indicates that the company is not currently navigating the complexities of multiple examiners or diverse art unit standards. For practitioners, this means that the current prosecution strategy is entirely focused on resolving the specific issues raised in this pending action within a single technical discipline.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STCLAIR, ANDREW D | 1 | 60.2% | +25.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17267025 | NS1-Binding Protein and Uses Thereof | STCLAIR, ANDREW D | 358d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17267025 | NS1-Binding Protein and Uses Thereof | STCLAIR, ANDREW D | 358d overdue |
| Art Unit | Apps |
|---|---|
| 2178 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17267025 | NS1-Binding Protein and Uses Thereof | STCLAIR, ANDREW D | 2178 | §101§112 | Non-Final OA | 358d overdue | Pending | Feb 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial